Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
Clinical trial NCT03969004 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03969004
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-04
- Primary completion
- 2028-01-07
- Enrollment
- 415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.